about
Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive reviewMast Cell-Targeted Strategies in Cancer TherapyProfile of brivaracetam and its potential in the treatment of epilepsyThe role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectivesTargeting mast cells in gastric cancer with special reference to bone metastasesUse of atypical antipsychotics in the elderly: a clinical reviewTargeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategyComparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.A questionnaire-based study on prevalence and treatment of headache in young childrenGlutamate metabotropic receptors as targets for drug therapy in epilepsyAntiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsyBidirectional effects of beta-carbolines in reflex epilepsyGenetics of reflex seizures and epilepsies in humans and animals.The sphingosine 1-phosphate signaling pathway in epilepsy: A possible role for the immunomodulator drug fingolimod in epilepsy treatment.Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents.Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy.Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman.A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment.The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasisLaxative-induced rhabdomyolysis.Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysisHypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy.Neuropharmacology of depression in aging and age-related diseases.Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures.Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis.Recurrence of atrial fibrillation after switching from brand to generic atenololRosacea-like facial rash related to metformin administration in a young woman.Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsyPerspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.AMPA receptor antagonists as potential anticonvulsant drugs.Increase in plasma homocysteine levels induced by drug treatments in neurologic patients.Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa.Adverse effects of atypical antipsychotics in the elderly: a review.Role of calcium in brain aging.Conventional and atypical antipsychotics in the elderly : a review.Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysisTumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.Drugs treatment of pain in multiple sclerosis.Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance.
P50
Q21284663-18AB4954-93F2-4814-98A2-1D0F7A137A0DQ26743796-FD167D21-0D3C-4053-A38F-5B299D5948BBQ26776317-530AEB19-E87D-499D-A6B0-DDB370786211Q26781186-5C7FE0FA-EB98-4054-BF27-D32F3604A2A7Q26784456-FD349C03-95DA-46DC-8510-F91737F03BCBQ26827756-2724A063-BD6D-4755-876C-64F3F3D647C4Q26863340-8C9BD264-D8E8-4A7D-9039-611AF9E569D1Q27339093-8A0EEF46-1134-4165-9CA4-E0A42CDA03B8Q28194006-45024403-F3A5-40A0-B2A0-DBD70DB94129Q28206435-185D2128-3943-46E1-816F-6D30B54DCEDDQ28280535-78E79026-9A82-43DB-BED6-A4911978D65BQ28290723-AAB92F13-A789-492D-806C-FCE24F08B901Q30384456-23BF884E-0783-407D-A0BF-FB40189E6255Q31141401-E86C3F73-D89C-458C-9689-16A5FBAE7E67Q33317745-CD1F611B-4720-41D6-9890-47BFE0C46A31Q33392937-A27D64A5-0A37-4FF5-B7C1-07DDFB43ABC0Q33408949-02B46505-33B7-452D-9D6E-3F0C383F9196Q33436051-978B53FF-2EF1-47FE-B4B9-96E9101C4A6FQ33449878-741B06AE-3DE5-48D3-9948-2240D605459AQ33787138-325CDFD8-3B29-4AE7-AEF5-74AEB190E487Q33902895-DBC068BD-FF69-4EAA-AB3C-DECC74193376Q34360600-13B0A960-E92E-49BB-BC93-4039604943D3Q34395565-DAADC6C9-06CA-44C4-99C5-C52D7D9E7D3FQ34662364-BC02C373-4D9A-44ED-88B1-53AE7974C358Q34714709-8105CA88-7751-4A39-9F4A-9D499CA2726BQ34758283-E0F5B089-C7EA-46C9-92ED-1A5826106302Q35056324-1EBDF0AE-5F4B-43A2-828F-906AB05417DCQ35089165-76CC5525-7F6A-4A98-8D3C-B3C9A2E9B781Q35693028-C3047548-D5B4-47AA-8C47-C46D9BA8FFF6Q35761335-2B1CCDD5-EC87-4736-98A5-E2899F1029C3Q36002935-0B95F99B-D1F2-4412-90C2-3EC2ACC7F7BEQ36204769-1CC8FBFE-FF51-4979-BEA8-DC20084A3CB0Q36566318-6E4727BD-039F-4831-A97E-6D4EDC93FD34Q36677274-89B55B56-1D9B-4AA8-8D12-FE9353FB8255Q36811949-571A8DA8-C7C6-4122-879F-A57867CA97F8Q36834289-A46C8F36-846B-4D09-90CF-29443965E01EQ36969387-61AC1A9F-FD77-45B6-8733-33C161855391Q37056978-E616F746-DF46-4F06-BE5D-2A330E46484BQ37239175-C6FB38C5-9E57-4C0E-9B2A-B9F21BA1CD6CQ37369618-11F36DBD-468F-486C-8A09-B94746EB76EB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giovambattista De Sarro
@ast
Giovambattista De Sarro
@en
Giovambattista De Sarro
@es
Giovambattista De Sarro
@nl
Giovambattista De Sarro
@sl
type
label
Giovambattista De Sarro
@ast
Giovambattista De Sarro
@en
Giovambattista De Sarro
@es
Giovambattista De Sarro
@nl
Giovambattista De Sarro
@sl
prefLabel
Giovambattista De Sarro
@ast
Giovambattista De Sarro
@en
Giovambattista De Sarro
@es
Giovambattista De Sarro
@nl
Giovambattista De Sarro
@sl
P106
P1153
7006396210
P21
P2456
P31
P496
0000-0002-7629-6579